Astrid Intelligence (ASTR) AI Stock Analysis

• Market Cap: £11.23M
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): 2.85
• Revenue Growth: -100.00%
• EPS Growth: 37.84%
• Country: UK
• Employees: 1
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): >-0.01
• Shares Outstanding: 6,327,666,000
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: <0.01
• Price to Book (P/B): 1.05
• Price to Sales (P/S): 30.21
• P/FCF Ratio: -0.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 39 Underperform
• Price Target: ―
• Action: N/A Date: 04/25/25
• Date: Action: N/A 04/25/25

The overall score reflects significant financial challenges, with ongoing profitability and cash flow issues as the primary concern. Technical indicators show some positive momentum, but high volatility and poor valuation metrics diminish the stock's appeal. The recent corporate events offer a potential upside if new leadership can successfully navigate strategic improvements.

Astrid Intelligence Business Overview & Revenue Model

Company Description

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom.

How the Company Makes Money

Cellular Goods Plc generates revenue primarily through the sale of its skincare and wellness products, which are distributed both online and through retail partnerships. The company focuses on leveraging advancements in biosynthetic cannabinoid production to create high-quality, sustainable consumer goods. Key revenue streams include direct-to-consumer sales via its e-commerce platform and wholesale partnerships with retailers. Cellular Goods also invests in research and development to expand its product line and improve its formulations, which can enhance its market position and drive future sales growth.

Astrid Intelligence Financial Statement Overview

Summary

Cellular Goods Plc is facing significant financial challenges, particularly in achieving profitability and positive cash flow. While revenue growth is a positive sign, the company struggles with operational efficiency, as shown by negative profit margins and cash flows. The balance sheet remains relatively sound due to a lack of debt, but declining equity and ongoing losses pose risks to financial stability. Overall, the company needs to focus on cost control and operational improvements to achieve sustainability.

Income Statement

The company has shown significant revenue growth from 2023 to 2024, with revenue increasing from 67,236 to 17,942. However, profitability remains a major concern, as reflected by negative EBIT and net profit margins. The negative margins indicate ongoing issues in controlling operational costs and achieving profitability.

Balance Sheet

The company has a solid equity base with no debt, resulting in a debt-to-equity ratio of zero. However, the return on equity is negative due to consistent net losses, indicating inefficiencies in generating returns for shareholders. The equity ratio shows a healthy proportion of equity in the asset structure, but the declining equity over the years is a concern.

Cash Flow

The company is experiencing negative free cash flow, indicating more cash outflow than inflow from operations and investments. The operating cash flow to net income ratio is negative due to persistent operating losses, suggesting challenges in converting revenue to cash. The free cash flow to net income ratio also highlights the inability to generate free cash flow relative to net income.

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Astrid Intelligence Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ASTR, the sentiment is Positive. The current price of 0.1 is below the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 52.17 is Neutral, neither overbought nor oversold. The STOCH value of 33.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ASTR.

Astrid Intelligence Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VLE	76 Outperform	£55.84M	7.35	10.95%	―	9.90%	37.20%
CODE	74 Outperform	£2.40M	14.20	6.74%	―	1.64%	―
WIL	70 Outperform	£235.53M	33.44	9.96%	3.78%	3.22%	-71.97%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
DIS	42 Neutral	£1.98M	-0.96	-21.81%	―	-25.00%	52.94%
ASTR	39 Underperform	£11.23M	-0.93	-263.11%	―	-100.00%	37.84%